Search research articles
Contact Us
Filters
Showing results (461-470 of 516) with videos related to
Page
of 52
Sort By:
Pediatric Blood & Cancer
|
October 12, 2021
Infantile myofibromatosis: Excellent prognosis but also rare fatal progressive disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry
Monika Sparber-Sauer, Christian Vokuhl, Guido Seitz, et al.
Journal of Surgical Oncology
|
November 14, 2018
Localized synovial sarcoma of the foot or ankle: A series of 32 Cooperative Weichteilsarkom Study Group patients
Monika Scheer, Michael Greulich, Steffan Loff, et al.
Frontiers in Nutrition
|
July 16, 2015
How the Organic Food System Supports Sustainable Diets and Translates These into Practice
Carola Strassner, Ivana Cavoski, Raffaella Di Cagno, et al.
Journal of Cancer Research and Clinical Oncology
|
June 10, 2022
Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma
Monika Scheer, Erika Hallmen, Christian Vokuhl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2013
Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group
Cornelia Eckert, Günter Henze, Karlheinz Seeger, et al.
Journal of Surgical Oncology
|
May 21, 2020
Dermatofibrosarcoma protuberans in children and adolescents: Primary and Relapsed disease-Experience of the Cooperative Weichteilsarkomstudiengruppe (CWS)
Julia Krewer, Udo Rolle, Ewa Koscielniak, et al.
Blood
|
October 16, 2004
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95
Wilhelm Woessmann, Kathrin Seidemann, Georg Mann, et al.
Leukemia
|
December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009
Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2023
Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry
Ewa Koscielniak, Beate Timmermann, Marc Münter, et al.
Pediatric Blood & Cancer
|
February 15, 2019
Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS)
Monika Sparber-Sauer, Sabine Stegmaier, Christian Vokuhl, et al.
Page
of 52
Search research articles
Search
Showing results (461-470 of 516) with videos related to
Sort By:
Page
of 52
Pediatric Blood & Cancer
|
October 12, 2021
Infantile myofibromatosis: Excellent prognosis but also rare fatal progressive disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry
Monika Sparber-Sauer, Christian Vokuhl, Guido Seitz, et al.
Journal of Surgical Oncology
|
November 14, 2018
Localized synovial sarcoma of the foot or ankle: A series of 32 Cooperative Weichteilsarkom Study Group patients
Monika Scheer, Michael Greulich, Steffan Loff, et al.
Frontiers in Nutrition
|
July 16, 2015
How the Organic Food System Supports Sustainable Diets and Translates These into Practice
Carola Strassner, Ivana Cavoski, Raffaella Di Cagno, et al.
Journal of Cancer Research and Clinical Oncology
|
June 10, 2022
Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma
Monika Scheer, Erika Hallmen, Christian Vokuhl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2013
Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group
Cornelia Eckert, Günter Henze, Karlheinz Seeger, et al.
Journal of Surgical Oncology
|
May 21, 2020
Dermatofibrosarcoma protuberans in children and adolescents: Primary and Relapsed disease-Experience of the Cooperative Weichteilsarkomstudiengruppe (CWS)
Julia Krewer, Udo Rolle, Ewa Koscielniak, et al.
Blood
|
October 16, 2004
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95
Wilhelm Woessmann, Kathrin Seidemann, Georg Mann, et al.
Leukemia
|
December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009
Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2023
Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry
Ewa Koscielniak, Beate Timmermann, Marc Münter, et al.
Pediatric Blood & Cancer
|
February 15, 2019
Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS)
Monika Sparber-Sauer, Sabine Stegmaier, Christian Vokuhl, et al.
Page
of 52